H2 Repairs Endothelial Progenitor Cells InjuryScientific Research
Hydrogen Repairs LPS-Induced Endothelial Progenitor Cells Injury via PI3K/AKT/eNOS Pathway
1
,
2
,
†
Kaixuan Lv,
3
,
†
Jielun Yu,
3
,
4
,
5
,
†
Shangmin Chu,
3
Lichun Zhang,
3
Lingyu Kong,
6
Linlin Zhang,
3
Yan Tian,
7
Xiaopeng Jia,
8
Benhong Liu,
9
,* Youzhen Wei,
10
,* and Nana Yang
3
,
4
,
5
,*
Abstract
Endotoxins and other harmful substances may cause an increase in permeability in endothelial cells (ECs) monolayers, as well as ECs shrinkage and death to induce lung damage. Lipopolysaccharide (LPS) can impair endothelial progenitor cells (EPCs) functions, including proliferation, migration, and tube formation. EPCs can migrate to the damaged area, differentiate into ECs, and participate in vascular repair, which improves pulmonary capillary endothelial dysfunction and maintains the integrity of the endothelial barrier. Hydrogen (H2) contributes to the repairment of lung injury and the damage of ECs. We therefore speculate that H2 protects the EPCs against LPS-induced damage, and it’s mechanism will be explored. The bone marrow-derived EPCs from ICR Mice were treated with LPS to establish a damaged model. Then EPCs were incubated with H2, and treated with PI3K inhibitor LY294002 and endothelial nitric oxide synthase (eNOS) inhibitor L-NAME. MTT assay, transwell assay and tube formation assay were used to detect the proliferation, migration and angiogenesis of EPCs. The expression levels of target proteins were detected by Western blot. Results found that H2 repaired EPCs proliferation, migration and tube formation functions damaged by LPS. LY294002 and L-NAME significantly inhibited the repaired effect of H2 on LPS-induced dysfunctions of EPCs. H2 also restored levels of phosphor-AKT (p-AKT), eNOS and phosphor-eNOS (p-eNOS) suppressed by LPS. LY294002 significantly inhibited the increase of p-AKT and eNOS and p-eNOS expression exposed by H2. L-NAME significantly inhibited the increase of eNOS and p-eNOS expression induced by H2. H2 repairs the dysfunctions of EPCs induced by LPS, which is mediated by PI3K/AKT/eNOS signaling pathway.
Introduction
Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are a series of pulmonary pathological changes arising from a wide variety of lung injuries, which have high morbidity and mortality (Butt et al., 2016), characterized by disruption of endothelial barrier integrity and diffuse lung damage. It can cause an imbalance between coagulation and inflammation to induce inflammation (Frantzeskaki et al., 2017). Besides, macrophages, neutrophils inflammatory cells and their pro-inflammatory products can destroy pulmonary epithelial cells, increase pulmonary microvascular permeability, produce pulmonary edema, damage gas exchange, and lead to respiratory failure (Butt et al., 2016). Therefore, how to maintain the integrity of the endothelial barrier through the regulation of the microenvironment in the inflammatory state is critical to the treatment.
ECs dysfunction and inflammation contribute to the occurrence and development of lung injury. Thus, vascular endothelial repair is an integral part of lung injury repair (Zhao et al., 2020). EPCs are a kind of progenitor cells that can differentiate into vascular ECs (Asahara et al., 1997), which can migrate to the damaged area and differentiate into ECs to participate in angiogenesis or repair, and promote the improvement of endothelial functions (Li et al., 2017). In addition, EPCs can repair the vascular injury and alleviate LPS-induced lung injury, reduce inflammation, and promote bacterial clearance of pneumonia (Mao et al., 2010), which has a broad prospect in the treatment of lung injury.
Hydrogen (H2) is an important physiological regulatory factor that has protective effects of anti-oxidation, anti-inflammation, and anti-apoptosis on cells and organs (Huang et al., 2010b). H2 can reduce oxidative stress (Song et al., 2011), promote the scavenging of free radicals, and inhibit vascular aging (Iketani et al., 2018). A multicenter, open-label clinical trial showed that hydrogen/oxygen mixed gas inhalation improved disease severity and dyspnea in patients with Coronavirus disease 2019 (COVID-19) (Guan et al., 2020). In addition, H2 has an excellent therapeutic effect on inflammation, ischemia-reperfusion injury, diabetes, cancer, atherosclerosis, and other diseases (Li et al., 2013Lee et al., 2015Shimada et al., 2016Li et al., 2019). It can reduce the levels of serum Low-Density Lipoprotein Cholesterol (LDL-C) and apolipoprotein- B (Apo-B), improve the high-density lipoprotein (HDL) functions damaged by dyslipidemia (Song et al., 2013), reduce the formation of neointima after vein transplantation in rats (Sun et al., 2012), and decrease hypertension, angiogenesis imbalance and oxidative stress caused by placental ischemia (Ushida et al., 2016). It also can protect the pulmonary microvessels of mice from the endothelial function damage induced by septicemia, maintain the consistency of pulmonary endothelium (Li Y. et al., 2020), and improve microvascular ECs viability in traumatic brain injury by inhibiting autophagy (Wang Y. et al., 2020). Animal experimental studies have shown that H2 inhalation can provide protection in animal models of lung injury caused by mechanical ventilation, sepsis, ischemia-reperfusion, LPS and hyperoxia, seawater infusion, etc. (Ohsawa et al., 2007Xie et al., 2010Chen et al., 2015Diao et al., 2016Audi et al., 2017). Clinical studies show that the inhalation of H2 by pregnant women can also inhibit the LPS-induced apoptosis and oxidative damage of fetal lung cells (Hattori et al., 2015). Previous studies have found that EPCs can repair lung injury induced by LPS (Yang et al., 2019), and H2 has the same effect (Hattori et al., 2015). We speculate that H2 may have a protective effect on EPCs, and even repair LPS-induced lung injury by improving the functions of EPCs. In this study, the injury model of EPCs was established by LPS treatment, and the cell viability, migration, angiogenic ability, and related protein expression of EPCs were measured. The molecular mechanisms of H2 on the functional damage and repair of EPCs induced by LPS were discussed.
Materials and Methods
Animals
ICR mice (4 weeks old, males) were obtained from the Cavens Company (Jiang Su, China). All animal experiments were approved by the Animal Experimental Ethics Committee of Weifang Medical University (approval code: 2019SDL108).
Isolation and Culture of EPCs
MNCs were isolated from the femurs of 4-week-old male ICR mice by density gradient centrifugation using Histopaque 1,083 (Sigma, St. Louis, MO, United States). The isolated MNC were seeded in a 6-well culture plate coated with fibronectin and cultured in EGM-2MV (Endothelial cell basal medium-2, plus FBS, VEGF, R-IGF-1, rhEGF, rhFGF-B, GA-1000, hydrocortisone and ascorbic acid) (Lonza, Basel, Switzerland). After 3 days of culture at 37°C with 5% CO2, the culture medium was changed thoroughly with fresh culture medium, and non-adherent cells were removed, and the culture medium was changed every 2 days.
Characterization of EPCs
MNCs from mice bone marrow were cultured for 5 days, incubated with 50 ug/ml Human Dil-Acetylated Low Density Lipoprotein (Dil-Ac-LDL, FuShen, Shanghai, China) at 37°C for 4 h. Then cells were fixed in 4% paraformaldehyde (PFA), incubated with FITC-labeled Ulex europaeus agglutinin 1 (FITC-UEA-1, FuShen, Shanghai, China) for 1 h. After setting the image acquisition parameters at each wavelength using background control, images were obtained under OLYMPUS, IX71 fluorescence microscope at 400x.
We further detected the expression of surface markers in cells at 10d and 21d. Cells were fixed in 4% PFA, treated with 0.1% Triton X-100 for 10 min. After being blocked with 5% FBS for 1 h at room temperature, the cells were incubated with primary antibodies against CD117 (C-Kit) (eBioscience, San Diego, CA, United States), SCA-1 (Abcam, Cambridge, MA, United States), VEGFR 2 (Abcam, Cambridge, MA, United States), CD31 (Abcam, Cambridge, MA, United States), eNOS (Cell Signaling Technologies, Danvers, MA, United States) overnight at 4°C. After being washed with PBS, EPCs were incubated with secondary antibodies conjugated with Cy3 (Goat anti-mouse cy3, 1:100, Proteintech Group, Chicago, IL, United States; Goat anti-Rat cy3, 1:100, Jackson Immunoresearch Laboratories, West Grove, PA, United States) or FITC (Goat anti-rabbit FITC, 1:100, Proteintech Group, Chicago, IL, United States) for 1 h at 37°C. The immunofluorescence staining was evaluated under a fluorescence microscope (OLYMPUS, IX71, 400x).
EPCs Treatment
Before the experiment, the cell culture medium was replaced by basic medium (M199 + 5% FBS). Then EPCs were treated with different concentrations (2.5 μg/ml, 5 μg/ml, 10 μg/ml, 20 μg/ml) of LPS (Solarbio, Beijing, China) at different time (24, 48, 72 h) to establish a damaged model. The cell damaged model was treated with H2 in different concentrations (20%, 40%, 60%) at different time (24, 48, 72 h) to explore the suitable conditions of H2. The concentration of CO2 in the H2 incubator is 5%, the concentration of O2 is 21%, and the concentration of H2 is adjusted by N2. Finally, EPCs were treated with PI3K inhibitor LY294002 (Sigma-Aldrich, St Louis, MO, United States) (10 μM, 20 μM, 30 μM) or eNOS inhibitor L-NAME (Beyotime, Shanghai, China) (100 μM, 200 μM) to find out the suitable concentration of inhibitors.
Cell Viability of EPCs
EPCs were evaluated by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay. Cells (100μl, 5×104 cells/mL) were seeded in 96-well plates and cultured for 24 h until adhered to the wall. After different treatments, cells were incubated with MTT (20 μl, 5 mg/ml) for 4 h at 37°C with 5% CO2. 200 μl of dimethylsulfoxide (DMSO) was added to each well and shaken for 10 min. The optical density (OD) values at 492 nm were determined using a microplate spectrophotometer (Multiskan GO, Thermo, United States).
EPCs Migration Assay
EPCs migration was measured by an 8 μm pore 24-well Cell Migration Assay kit (BD Biosciences, San Jose, CA, United States). EPCs suspension (300 μl, 5×104 cells/mL in M199 medium) was added to the upper chamber and cultured according to different groups, and 600 μl EGM-2MV medium was added lower chamber. After different treatments, the chamber was taken out, scrubbed carefully with a cotton swab and rinsed with PBS. The lower cells were fixed and stained with 0.1% crystal violet. Carefully cut off the Polycarbonate film from the base of the upper chamber, seal the film and take a picture under a microscope.
Tube Formation in Vitro
Matrigel (BD Biosciences, San Jose, CA, United States) matrix was dissolved overnight at 4°C. After being placed in a 37°C incubator for 30min, 250 μl Matrigel was added to a 24-well plate. After treatments, 5×104 cells were seeded in the Matrigel-coated plate. After 6 h incubation, Calcein AM was added to staining for 30 min, and the samples were observed and photographed under a fluorescence microscope.
Western Blot
Total protein was extracted with Radio immunoprecipitation assay (RIPA, Beyotime, Shanghai, China) lysis buffer and quantified with a BCA assay kit (Solarbio, Beijing, China). In total, 25 μg of protein was electrophoresed on a 10% denaturing polyacrylamide gel and transferred onto polyvinylidene difluoride (PVDF) membranes. After being blocked with 7% dried skimmed milk for 3 h at room temperature, the membranes were incubated with primary antibodies against GAPDH (1: 20,000, Proteintech Group, Chicago, IL, United States), AKT (1: 1,000, Proteintech Group, Chicago, IL, United States), p-AKT (1: 2000, Proteintech Group, Chicago, IL, United States), eNOS (1: 1,000, Cell Signaling Technologies, Danvers, MA, United States), p-eNOS (1: 1,000, Cell Signaling Technologies, Danvers, MA, United States) overnight at 4 °C under constant shaking. After washing with TBST buffer (Shandong Sparkjade Biotechnology Co., Ltd.) 4 times (each 5min), the membranes were incubated with the secondary antibodies conjugated to horseradish peroxidase (HRP) for 3 h at room temperature under constant shaking. After washing with TBST buffer for three times (each 5 min), the protein bands on the PVDF membrane were detected using the ECL chemiluminescence detection kit and chemiluminescence gel imaging system (FluorChem Q, ProteinSimple, CA, United States).
Statistical Analyses
All data are presented as mean ± standard deviation (SD). The data were analyzed using SPSS software (version 26.0, SPSS Inc., Chicago, IL, United States). Differences between three groups or more were analyzed by one-way ANOVA. Values were considered significant at p < 0.05.
Results
Isolation and Characterization of EPCs
Bone marrow mononuclear cells (MNCs) isolated from mouse bone marrow showed cobblestone-like morphology (Supplementary Figure 1). These induced MNCs engulfed Dil-ac-LDL and FITC-UEA-1 (Figure 1A), the differentiation markers of EPCs. Then we examined cell-surface markers of EPCs. After 10 days of culture, VEGFR-2 with C-kit were co-expressed in the isolated cells (Figure 1B), and VEGFR-2 with SCA-1 were also co-expressed. (Figure 1C). After 21 days of culture, the cells expressed both eNOS and CD31. (Figure 1D). Therefore, these induced MNCs were characterized as EPCs and could be used in later experiments.
Isolation and characterization of mice bone marrow-derived EPCs. (A) DiI-ac-LDL (red) and FITC-UEA-1 (green) could be taken up by EPCs (blue) and merged images of red and green fluorescence. Scale bar = 20 μm (400x). (B) Co-expression of VEGFR-2 (green) with C-kit (red) in cells at 10 d. (C) Co-expression of VEGFR-2 (green) with SCA-1 (red) in cells at 10 d. (D) Co-expression of eNOS (green) with CD31 (red) in cells at 21 days. Scale bar = 20 μm (400x).
LPS Impaired EPCs Functions
MTT assay results showed that, compared with the control group, LPS reduced the viability of EPCs in a concentration-dependent and time-dependent manner. We used 20 μg/ml LPS to induce 72 h for the follow-up experiments (Figure 2). In addition, we also found that LPS significantly reduced the ability of migration and tube formation of EPCs (Figures 3B–E).
EPCs viability was reduced after being induced by LPS. EPCs were treated with different concentrations (2.5 μg/ml, 5 μg/ml, 10 μg/ml, 20 μg/ml) LPS for different time (24, 48, 72 h). Cell viability was measured by MTT assay. Data are presented as mean ± SD (n = 6); **p < 0.01.
H2 alleviated EPCs dysfunctions induced by LPS. EPCs treated with LPS induced EPCs damage, and then EPCs were treated with different concentrations (20%, 40%, 60%) for different time (24, 48, 72 h). The viability of EPCs was assessed by MTT assay (A). EPCs migration was measured by transwell assay (B,C). Tube formation was measured by a Tube formation assay (D,E). Data are presented as mean ± SD (n = 6); **p < 0.01.
H2 Alleviated LPS-Induced EPCs Dysfunctions
Compared with the control group, LPS reduced the viability of EPCs. H2 significantly improved the LPS-induced reduction in EPCs viability in a concentration-dependent and time-dependent manner, and the effect of 60% concentration of H2 on EPCs for 72 h was the most significant (Figure 3A).
Migration assay showed that LPS reduced EPCs migration ability, compared with the control group. H2 reversed the LPS-induced changes. H2 increased the migration of EPCs in a concentration-dependent and time-dependent manner, and 60% concentration of H2 treatment for 72 h has the most significant effect on the repairment of EPCs migration ability (Figure 3 B and C).
The EPCs tube formation was detected with tube formation assay. Compared with the control group, LPS reduces the tube formation of EPCs, which could be reversed by H2 treatment in a concentration-dependent manner (Figure 3 D and E).
LY294002 and L-NAME Inhibited H2-Mediated Restoration of EPCs Functions
The effects of specific inhibitors LY294002 (PI3K inhibitor) and L-NAME (eNOS inhibitor) on EPCs functions were measured to investigate the protective mechanism of H2. As shown in Figure 4 A and B, LY294002 (10 μM, 20 μM, 30 μM) and L-NAME (100 μM, 200 μM) inhibited the H2-mediated restoration of EPCs viability impaired by LPS. 20 μM LY294002 and 200 μM L-NAME were employed in the subsequent experiments. Figure 4 C-E showed that LY294002 and L-NAME significantly inhibited the H2-mediated restoration of EPCs migration and tube formation ability damaged by LPS.
LY294002 and L-NAME inhibited the H2-induced repair of EPCs dysfunctions damaged by LPS. EPCs were treated with the PI3K inhibitor LY294002 (10 μM, 20 μM, 30 μM) or the eNOS inhibitor L-NAME (100 μM, 200 μM), incubated with LPS (20 μg/ml) and H2 (60%) for 72 h. The viability of EPCs was assessed by MTT assay (A,B), n = 6). EPCs migration was measured by transwell assay (C,D)
n = 15. Tube formation was measured by Tube formation assay (E,F)
n = 15. Data are presented as mean ± SD; *p < 0.05 and **p < 0.01.,
H2 Restored the PI3K/AKT/eNOS Pathway Inhibited by LPS
We further investigated the protein levels of AKT, p-AKT, eNOS and p-eNOS to clarify the relationship between H2 and PI3K/AKT/eNOS signaling pathway. As shown in Figure 5, LPS (20 μg/ml) decreased the protein levels of p-AKT, eNOS, p-eNOS in EPCs. H2 restored these protein levels in a time-dependent manner, and H2 treatment for 2 h was employed in the subsequent experiments. As shown in Figure 6, LY294002 significantly inhibited the increased levels of p-AKT, eNOS, p-eNOS induced by 60% H2. Figure 7 showed that L-NAME significantly inhibited the increased levels of eNOS and p-eNOS induced by 60% H2, however, there was no effect of L-NAME on the expression levels of p-AKT.
(A) Representative western blot images. H2 up-regulated the levels of p-AKT (B), eNOS (C), and p-eNOS (D) in EPCs at different time points. Cells were treated with LPS (20 μg/ml) and H2 (60%) for 0, 1, 1.5 and 2 h, respectively. Western blotting was used to detect the expression levels of target protein. Data are presented as mean ± SD; **p < 0.01.
(A) Representative western blot images. LY294002 inhibited the increase of p-AKT (B), eNOS (C) and p-eNOS (D) expression induced by H2 (60%). Cells were treated with LPS (20 μg/ml), H2 (60%) and LY294002 (20 μM) for 2 h, respectively. Western blotting was used to detect the expression levels of target protein. Data are presented as mean ± SD; **p < 0.01.
(A) Representative western blot images. L-NAME inhibited the increase of eNOS (C) and p-eNOS (D) expression induced by H2 (60%), and did not affect p-AKT levels (B). Cells were treated with LPS (20 μg/ml), H2 (60%) and L-NAME (200 μM) for 2 h, respectively. Western blotting was used to detect the expression levels of target protein. Data are presented as mean ± SD; **p < 0.01.
Discussion
EPCs were first initially discovered in 1997 by Asahara et al. EPCs are defined as a cell population capable of differentiating into mature ECs and have vasculogenic potential, which contributes to vasculogenic, wound healing (Asahara et al., 1997) and repair of ischemic tissue damage (Fan et al., 2014). As a potential therapeutic agent, EPCs have attracted attention for a variety of diseases including cerebral ischemia (Zhou et al., 2021), diabetes (Wang K. et al., 2020), ALI etc. (Asahara et al., 1997). However, due to differences in the isolation, amplification and identification of EPCs, as well as controversy over therapeutic function, the further development and clinical application of EPCs were limited. In this study, we successfully isolated the mouse bone marrow-derived EPCs for subsequent research of the repair mechanism of H2 on EPCs dysfunctions induced by LPS. This study is the first report of the effect of H2 on EPCs.
H2 is an odorless, colorless, tasteless, and insoluble multifunctional medical gas. It can cross the cellular membranes and has the functions of anti-oxidation, anti-inflammatory and anti-apoptosis (Hong et al., 2010). In 1975, Dole et al. found that high-pressure hydrogen gas has an antioxidant effect and can inhibit the growth of tumors in mice (Dole et al., 1975). However, the study was not taken seriously because of the limitations of the experiment and the difficulty of reproducibility. In recent years, research on H2 in the medical field has gradually widened. Clinical studies have found that H2 plays a therapeutic role in diseases which related to the respiratory system (Guan et al., 2020), nervous system, cardiovascular (Camara et al., 2019), digestive system (Eryilmaz et al., 2020), reproductive system, urinary system (Gokalp et al., 2017), and metabolic exercise (Qiu et al., 2020). It is recommended to inhale a mixture of H2 and oxygen (O2) (33.3% O2 and 66.6% H2) in the “Clinical Guidance for COVID-19 Pneumonia Diagnosis and Treatment (Trial Version 7)” issued by the China National Health Commission. The recommendation recognized the importance of H2 in contemporary medical gas research.
In this study, LPS (20 μg/ml) significantly reduced the proliferation, migration, and tube formation of EPCs. This is consistent with Yu et al. research, which found that LPS (10 μg/ml) impaired the viability, migration, adhesion abilities, and tube formation of late EPCs (Yu et al., 2017). Compared with the control group, the proliferation and adhesion activities of bone marrow-derived EPCs were impaired in LPS (100 ng/ml) induced group in dose and time dependence (Li et al., 2014). Our previous study also demonstrated that LPS (30 μg/ml) inhibited the proliferation, migration, and tube formation of EPCs (Yang et al., 2019). Furthermore, western blot results showed that LPS reduced the expression levels of p-AKT, eNOS, and p-eNOS in EPCs. LPS had no effect on AKT expression. Our previous research proved that LPS (30 μg/ml) decreases the levels of p-AKT, eNOS, and p-eNOS in EPCs (Yang et al., 2019). Yang et al. found that LPS (10 μg/ml) reduced the expression of p-eNOS in human pulmonary microvascular endothelial cells (HPMECs) (Yang et al., 2018). Liu et al. found that p-AKT was markedly suppressed in H9c2 cells after treatment with LPS (1 μg/ml) for 24 h (Liu et al., 2021). The effect of LPS on AKT expression in out study was consistent with the study of Li et al. and Zhan et al. Li et al. showed that there was no significant change in AKT expression of LPS-induced (20 μg/ml) mouse microvascular ECs (Li H. et al., 2020). Zhan et al. reported that the AKT level of HPMECs did not change markedly under LPS (1 mg/L) induction (Zhan et al., 2020). In addition, Wang et al. found that p-AKT protein expression was significantly increased in LPS-induced (100 ng/ml) rat microvascular ECs (Wang et al., 2013). Fan et al. found that LPS (100 ng/ml) stimulation significantly increased the phosphorylation of both AKT and eNOS in HPMECs (Fan et al., 2020). Taken together, we speculate that the inconsistent study results may be due to the differences in LPS concentration. In addition to toxic effects, LPS also has extensive biological activity. Low doses of LPS have immune-activating effects (Morris and Li, 2012) (Lin et al., 2009). Therefore, there are differences in the functional gene expression and cell functions under different concentrations LPS treatment. However, the relevant mechanism still needs further confirmation.
The effectiveness of molecular hydrogen has been proven in the prevention and treatment of many diseases. H2 had a protective effect on the rat model of ALI (Jiang et al., 2013Audi et al., 2017) by significantly improving lung endothelial permeability, reducing cell apoptosis and histopathological changes (Diao et al., 2016), and preventing LPS-induced pulmonary ECs dysfunction (Li Y. et al., 2020). Fu et al. demonstrated that hydrogen-rich saline has a protective effect on LPS-induced ALI by regulating cell apoptosis and inhibiting endothelial dysfunction (Fu et al., 2020). Inhalation was the most direct way to administer molecular hydrogen (Huang et al., 2010aKawamura et al., 2010). At the same time, molecular hydrogen could be dissolved in physiological saline to make hydrogen-rich water for intravenous injection, or it could be taken orally (Cardinal et al., 2010He et al., 2013). A hydrogen incubator was used in this study. It could simulate the in vivo environment after inhaling hydrogen, which was more conducive to our research. H2 has a protective effect on the ECs barrier, mechanism of which has not been fully elucidated, and the effect of H2 on EPCs has not been reported. Our study indicated that H2 attenuated the dysfunctions of EPCs induced by LPS, improved EPCs proliferation, migration, tube formation, and restored the expression levels of p-AKT, eNOS, p-eNOS. Recent studies revealed that H2 could inhibit the expression of inflammatory factors, reduce sepsis-induced endothelial damage and inflammation, improve endothelial dysfunction (Cardinal et al., 2010He et al., 2013).
Previous studies showed that the PI3K/AKT/eNOS pathway is involved in the changes of the LPS-induced ECs barrier function (Zheng et al., 2018), but whether it is involved in the effect of H2 on EPCs repairment remains unclear. The results of the present study discovered the unique molecular basis for H2 to inhibit LPS-induced EPCs dysfunctions. After inhibiting the PI3K/AKT/eNOS signaling pathway by LY294002 and L-NAME, the H2-mediated restoration of EPCs functions was partially prevented. The western blot results demonstrated that H2 up-regulated p-AKT, eNOS and p-eNOS levels were inhibited by LPS. LY294002 significantly inhibited the increase of p-AKT, eNOS and p-eNOS induced by 60% H2. L-NAME significantly inhibited the increase of eNOS and p-eNOS induced by 60% H2, and had no effect on p-AKT levels. PI3K/AKT/eNOS activation plays a crucial role in our study. PI3K/AKT signaling pathway mediates a variety of pathophysiological processes and involves multiple important cellular activities, such as cell proliferation, apoptosis and autophagy (Ravikumar et al., 2010Liby and Sporn, 2012Saiprasad et al., 2014). Additionally, numerous studies show that the PI3K/AKT signaling pathway plays a vital role in the process of EPCs proliferation, migration, homing and tube formation (Everaert et al., 2010Wang et al., 2011). Our previous results demonstrate that Rev-D4F mediates restoration of EPCs functions by PI3K/AKT/eNOS signaling pathway (Yang et al., 2019). The PI3K/AKT/eNOS pathway was involved in restoring the dysfunctions of EPCs in diabetic mice (Cao et al., 2017). Yu et al. suggested that the proliferation, migration and survival of EPCs impaired by LDL cholesterol via the PI3K/AKT signaling pathway (Yu et al., 2010).
In summary, we concluded that the PI3K/AKT/eNOS signaling pathway was contributed to H2 repairment of EPCs dysfunctions induced by LPS (Figure 8).
H2-mediated restoration of EPCs dysfunctions is mediated by the PI3K/AKT/eNOS pathway.
Conclusion
Our results showed that H2 reversed the LPS-induced EPCs dysfunctions. Moreover, H2 restored the LPS-attenuated levels of p-AKT, eNOS and p-eNOS. Therefore, this study proves that H2-mediated restoration of EPCs dysfunctions is mediated by the PI3K/AKT/eNOS pathway.
Data Availability Statement
The raw data supporting the conclusion of this article will be made available by the authors, without undue reservation.
Ethics Statement
The animal study was reviewed and approved by All animal experiments were approved by the Animal Experimental Ethics Committee of Weifang Medical University (approval code: 2019SDL108).
Author Contributions
YW, NY, and BL, Conceptualization. QM and KL, Data curation. JY, Formal analysis. NY, Funding acquisition. QM, KL, JY, SC, LcZ, LK, LlZ, XJ, and YT, Investigation. QM, YW, KL, JY, and SC, Methodology. YW, NY, and BL, Project administration. LK, Software. QM, YW, KL, LcZ, LlZ, and SC, Validation. KL and JY, Writing–original draft. NY, Writing–review and editing.
Funding
This research was funded by the National Natural Science Foundation of China (No. 81600360), the Province Natural Science Foundation of Shandong (No. ZR2020KH008 and No. ZR2012HL18), the Province Science and Technology Development Foundation of Shandong (2014GSF118105), the Province Higher University Science and Technology Development Project of Shandong (No. J14LK03) the Yuandu Scholar Project, the Introduction Plan of Young Creative Talents in Colleges and Universities of Shandong Province (No. 205), Shanghai Asclepius Meditec Co., Ltd.
Conflict of Interest
XJ was employed by the Shandong Qilu Stem Cell Engineering Co.
The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary Material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fphar.2022.894812/full#supplementary-material
References
Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., et al. (1997). Isolation of Putative Progenitor Endothelial Cells for Angiogenesis. Science
275 (5302), 964–967. 10.1126/science.275.5302.964
[PubMed] [CrossRef] [Google Scholar]
Audi S. H., Jacobs E. R., Zhang X., Camara A. K. S., Zhao M., Medhora M. M., et al. (2017). Protection by Inhaled Hydrogen Therapy in a Rat Model of Acute Lung Injury Can Be Tracked In Vivo Using Molecular Imaging. Shock
48 (4), 467–476. 10.1097/shk.0000000000000872
[PMC free article] [PubMed] [CrossRef] [Google Scholar]
Butt Y., Kurdowska A., Allen T. C. (2016). Acute Lung Injury: A Clinical and Molecular Review. Arch. Pathol. Lab. Med.
140 (4), 345–350. 10.5858/arpa.2015-0519-RA
[PubMed] [CrossRef] [Google Scholar]
Camara R., Matei N., Camara J., Enkhjargal B., Tang J., Zhang J. H. (2019). Hydrogen Gas Therapy Improves Survival Rate and Neurological Deficits in Subarachnoid Hemorrhage Rats: a Pilot Study. Med. Gas. Res.
9 (2), 74–79. 10.4103/2045-9912.260648
[PMC free article] [PubMed] [CrossRef] [Google Scholar]
Cao W., Cui J., Li S., Zhang D., Guo Y., Li Q., et al. (2017). Crocetin Restores Diabetic Endothelial Progenitor Cell Dysfunction by Enhancing NO Bioavailability via Regulation of PI3K/AKT-eNOS and ROS Pathways. Life Sci.
181, 9–16. 10.1016/j.lfs.2017.05.021
[PubMed] [CrossRef] [Google Scholar]
Cardinal J. S., Zhan J., Wang Y., Sugimoto R., Tsung A., McCurry K. R., et al. (2010). Oral Hydrogen Water Prevents Chronic Allograft Nephropathy in Rats. Kidney Int.
77 (2), 101–109. 10.1038/ki.2009.421
[PubMed] [CrossRef] [Google Scholar]
Chen H., Xie K., Han H., Li Y., Liu L., Yang T., et al. (2015). Molecular Hydrogen Protects Mice against Polymicrobial Sepsis by Ameliorating Endothelial Dysfunction via an Nrf2/HO-1 Signaling Pathway. Int. Immunopharmacol.
28 (1), 643–654. 10.1016/j.intimp.2015.07.034
[PubMed] [CrossRef] [Google Scholar]
Diao M., Zhang S., Wu L., Huan L., Huang F., Cui Y., et al. (2016). Hydrogen Gas Inhalation Attenuates Seawater Instillation-Induced Acute Lung Injury via the Nrf2 Pathway in Rabbits. Inflammation
39 (6), 2029–2039. 10.1007/s10753-016-0440-1
[PubMed] [CrossRef] [Google Scholar]
Dole M., Wilson F. R., Fife W. P. (1975). Hyperbaric Hydrogen Therapy: a Possible Treatment for Cancer. Science
190 (4210), 152–154. 10.1126/science.1166304
[PubMed] [CrossRef] [Google Scholar]
Eryilmaz S., Turkyilmaz Z., Karabulut R., Gulburun M. A., Poyraz A., Gulbahar O., et al. (2020). The Effects of Hydrogen-Rich Saline Solution on Intestinal Anastomosis Performed after Intestinal Ischemia Reperfusion Injury. J. Pediatr. Surg.
55 (8), 1574–1578. 10.1016/j.jpedsurg.2019.07.018
[PubMed] [CrossRef] [Google Scholar]
Everaert B. R., Van Craenenbroeck E. M., Hoymans V. Y., Haine S. E., Van Nassauw L., Conraads V. M., et al. (2010). Current Perspective of Pathophysiological and Interventional Effects on Endothelial Progenitor Cell Biology: Focus on PI3K/AKT/eNOS Pathway. Int. J. Cardiol.
144 (3), 350–366. 10.1016/j.ijcard.2010.04.018
[PubMed] [CrossRef] [Google Scholar]
Fan H., Goodwin A. J., Chang E., Zingarelli B., Borg K., Guan S., et al. (2014). Endothelial Progenitor Cells and a Stromal Cell-Derived Factor-1α Analogue Synergistically Improve Survival in Sepsis. Am. J. Respir. Crit. Care Med.
189 (12), 1509–1519. 10.1164/rccm.201312-2163OC
[PMC free article] [PubMed] [CrossRef] [Google Scholar]
Fan S., Qi D., Yu Q., Tang X., Wen X., Wang D., et al. (2020). Intermedin Alleviates the Inflammatory Response and Stabilizes the Endothelial Barrier in LPS-Induced ARDS through the PI3K/Akt/eNOS Signaling Pathway. Int. Immunopharmacol.
88, 106951. 10.1016/j.intimp.2020.106951
[PubMed] [CrossRef] [Google Scholar]
Frantzeskaki F., Armaganidis A., Orfanos S. E. (2017). Immunothrombosis in Acute Respiratory Distress Syndrome: Cross Talks between Inflammation and Coagulation. Respiration
93 (3), 212–225. 10.1159/000453002
[PubMed] [CrossRef] [Google Scholar]
Fu Z., Zhang Z., Wu X., Zhang J. (2020). Hydrogen-Rich Saline Inhibits Lipopolysaccharide-Induced Acute Lung Injury and Endothelial Dysfunction by Regulating Autophagy through mTOR/TFEB Signaling Pathway. Biomed. Res. Int.
2020, 9121894. 10.1155/2020/9121894
[PMC free article] [PubMed] [CrossRef] [Google Scholar]
Gokalp N., Basaklar A. C., Sonmez K., Turkyilmaz Z., Karabulut R., Poyraz A., et al. (2017). Protective Effect of Hydrogen Rich Saline Solution on Experimental Ovarian Ischemia Reperfusion Model in Rats. J. Pediatr. Surg.
52 (3), 492–497. 10.1016/j.jpedsurg.2016.10.006
[PubMed] [CrossRef] [Google Scholar]
Guan W. J., Wei C. H., Chen A. L., Sun X. C., Guo G. Y., Zou X., et al. (2020). Hydrogen/oxygen Mixed Gas Inhalation Improves Disease Severity and Dyspnea in Patients with Coronavirus Disease 2019 in a Recent Multicenter, Open-Label Clinical Trial. J. Thorac. Dis.
12 (6), 3448–3452. 10.21037/jtd-2020-057
[PMC free article] [PubMed] [CrossRef] [Google Scholar]
Hattori Y., Kotani T., Tsuda H., Mano Y., Tu L., Li H., et al. (2015). Maternal Molecular Hydrogen Treatment Attenuates Lipopolysaccharide-Induced Rat Fetal Lung Injury. Free Radic. Res.
49 (8), 1026–1037. 10.3109/10715762.2015.1038257
[PubMed] [CrossRef] [Google Scholar]
He B., Zhang Y., Kang B., Xiao J., Xie B., Wang Z. (2013). Protection of Oral Hydrogen Water as an Antioxidant on Pulmonary Hypertension. Mol. Biol. Rep.
40 (9), 5513–5521. 10.1007/s11033-013-2653-9
[PMC free article] [PubMed] [CrossRef] [Google Scholar]
Hong Y., Chen S., Zhang J. M. (2010). Hydrogen as a Selective Antioxidant: a Review of Clinical and Experimental Studies. J. Int. Med. Res.
38 (6), 1893–1903. 10.1177/147323001003800602
[PubMed] [CrossRef] [Google Scholar]
Huang C. S., Kawamura T., Lee S., Tochigi N., Shigemura N., Buchholz B. M., et al. (2010a). Hydrogen Inhalation Ameliorates Ventilator-Induced Lung Injury. Crit. Care
14 (6), R234. 10.1186/cc9389
[PMC free article] [PubMed] [CrossRef] [Google Scholar]
Huang C. S., Kawamura T., Toyoda Y., Nakao A. (2010b). Recent Advances in Hydrogen Research as a Therapeutic Medical Gas. Free Radic. Res.
44 (9), 971–982. 10.3109/10715762.2010.500328
[PubMed] [CrossRef] [Google Scholar]
Iketani M., Sekimoto K., Igarashi T., Takahashi M., Komatsu M., Sakane I., et al. (2018). Administration of Hydrogen-Rich Water Prevents Vascular Aging of the Aorta in LDL Receptor-Deficient Mice. Sci. Rep.
8 (1), 16822. 10.1038/s41598-018-35239-0
[PMC free article] [PubMed] [CrossRef] [Google Scholar]
Jiang H., Yu P., Qian D. H., Qin Z. X., Sun X. J., Yu J., et al. (2013). Hydrogen-rich Medium Suppresses the Generation of Reactive Oxygen Species, Elevates the Bcl-2/Bax Ratio and Inhibits Advanced Glycation End Product-Induced Apoptosis. Int. J. Mol. Med.
31 (6), 1381–1387. 10.3892/ijmm.2013.1334
[PubMed] [CrossRef] [Google Scholar]
Kawamura T., Huang C. S., Tochigi N., Lee S., Shigemura N., Billiar T. R., et al. (2010). Inhaled Hydrogen Gas Therapy for Prevention of Lung Transplant-Induced Ischemia/reperfusion Injury in Rats. Transplantation
90 (12), 1344–1351. 10.1097/TP.0b013e3181fe1357
[PubMed] [CrossRef] [Google Scholar]
Lee P. C., Yang Y. Y., Huang C. S., Hsieh S. L., Lee K. C., Hsieh Y. C., et al. (2015). Concomitant Inhibition of Oxidative Stress and Angiogenesis by Chronic Hydrogen-Rich Saline and N-Acetylcysteine Treatments Improves Systemic, Splanchnic and Hepatic Hemodynamics of Cirrhotic Rats. Hepatol. Res.
45 (5), 578–588. 10.1111/hepr.12379
[PubMed] [CrossRef] [Google Scholar]
Li F. Y., Zhu S. X., Wang Z. P., Wang H., Zhao Y., Chen G. P. (2013). Consumption of Hydrogen-Rich Water Protects against Ferric Nitrilotriacetate-Induced Nephrotoxicity and Early Tumor Promotional Events in Rats. Food Chem. Toxicol.
61, 248–254. 10.1016/j.fct.2013.10.004
[PubMed] [CrossRef] [Google Scholar]
Li H., Kong R., Wan B., Yang L., Zhang S., Cao X., et al. (2020a). Initiation of PI3K/AKT Pathway by IGF-1 Decreases Spinal Cord Injury-Induced Endothelial Apoptosis and Microvascular Damage. Life Sci.
263, 118572. 10.1016/j.lfs.2020.118572
[PubMed] [CrossRef] [Google Scholar]
Li H., Qiang Y., Wang L., Liu C., Yang N., Xiong L., et al. (2014). Effect of Lipopolysaccharide on the Characteristics of Endothelial Progenitor Cells from Bone Marrow in Mice. Mol. Med. Rep.
9 (2), 427–434. 10.3892/mmr.2013.1833
[PMC free article] [PubMed] [CrossRef] [Google Scholar]
Li L., Liu H., Xu C., Deng M., Song M., Yu X., et al. (2017). VEGF Promotes Endothelial Progenitor Cell Differentiation and Vascular Repair through Connexin 43. Stem Cell Res. Ther.
8 (1), 237. 10.1186/s13287-017-0684-1
[PMC free article] [PubMed] [CrossRef] [Google Scholar]
Li L., Liu T., Li X., Liu X., Liu L., Li S., et al. (2019). Protein Chip and Bioinformatic Analyses of Differentially Expressed Proteins Involved in the Effect of Hydrogen-Rich Water on Myocardial Ischemia-Reperfusion Injury. Int. J. Med. Sci.
16 (9), 1254–1259. 10.7150/ijms.35984
[PMC free article] [PubMed] [CrossRef] [Google Scholar]
Li Y., Chen H., Shu R., Zhang X., Yu Y., Liu X., et al. (2020b). Hydrogen Treatment Prevents Lipopolysaccharide-Induced Pulmonary Endothelial Cell Dysfunction through RhoA Inhibition. Biochem. Biophys. Res. Commun.
522 (2), 499–505. 10.1016/j.bbrc.2019.11.101
[PubMed] [CrossRef] [Google Scholar]
Liby K. T., Sporn M. B. (2012). Synthetic Oleanane Triterpenoids: Multifunctional Drugs with a Broad Range of Applications for Prevention and Treatment of Chronic Disease. Pharmacol. Rev.
64 (4), 972–1003. 10.1124/pr.111.004846
[PMC free article] [PubMed] [CrossRef] [Google Scholar]
Lin H. Y., Huang C. C., Chang K. F. (2009). Lipopolysaccharide Preconditioning Reduces Neuroinflammation against Hypoxic Ischemia and Provides Long-Term Outcome of Neuroprotection in Neonatal Rat. Pediatr. Res.
66 (3), 254–259. 10.1203/PDR.0b013e3181b0d336
[PubMed] [CrossRef] [Google Scholar]
Liu L., Yan M., Yang R., Qin X., Chen L., Li L., et al. (2021). Adiponectin Attenuates Lipopolysaccharide-Induced Apoptosis by Regulating the Cx43/PI3K/AKT Pathway. Front. Pharmacol.
12, 644225. 10.3389/fphar.2021.644225
[PMC free article] [PubMed] [CrossRef] [Google Scholar]
Mao M., Wang S. N., Lv X. J., Wang Y., Xu J. C. (2010). Intravenous Delivery of Bone Marrow-Derived Endothelial Progenitor Cells Improves Survival and Attenuates Lipopolysaccharide-Induced Lung Injury in Rats. Shock
34 (2), 196–204. 10.1097/SHK.0b013e3181d49457
[PubMed] [CrossRef] [Google Scholar]
Morris M., Li L. (2012). Molecular Mechanisms and Pathological Consequences of Endotoxin Tolerance and Priming. Arch. Immunol. Ther. Exp. Warsz.
60 (1), 13–18. 10.1007/s00005-011-0155-9
[PubMed] [CrossRef] [Google Scholar]
Ohsawa I., Ishikawa M., Takahashi K., Watanabe M., Nishimaki K., Yamagata K., et al. (2007). Hydrogen Acts as a Therapeutic Antioxidant by Selectively Reducing Cytotoxic Oxygen Radicals. Nat. Med.
13 (6), 688–694. 10.1038/nm1577
[PubMed] [CrossRef] [Google Scholar]
Qiu X., Ye Q., Sun M., Wang L., Tan Y., Wu G. (2020). Saturated Hydrogen Improves Lipid Metabolism Disorders and Dysbacteriosis Induced by a High-Fat Diet. Exp. Biol. Med. (Maywood)
245 (6), 512–521. 10.1177/1535370219898407
[PMC free article] [PubMed] [CrossRef] [Google Scholar]
Ravikumar B., Sarkar S., Davies J. E., Futter M., Garcia-Arencibia M., Green-Thompson Z. W., et al. (2010). Regulation of Mammalian Autophagy in Physiology and Pathophysiology. Physiol. Rev.
90 (4), 1383–1435. 10.1152/physrev.00030.2009
[PubMed] [CrossRef] [Google Scholar]
Saiprasad G., Chitra P., Manikandan R., Sudhandiran G. (2014). Hesperidin Induces Apoptosis and Triggers Autophagic Markers through Inhibition of Aurora-A Mediated Phosphoinositide-3-kinase/Akt/mammalian Target of Rapamycin and Glycogen Synthase Kinase-3 Beta Signalling Cascades in Experimental Colon Carcinogenesis. Eur. J. Cancer
50 (14), 2489–2507. 10.1016/j.ejca.2014.06.013
[PubMed] [CrossRef] [Google Scholar]
Shimada S., Wakayama K., Fukai M., Shimamura T., Ishikawa T., Fukumori D., et al. (2016). Hydrogen Gas Ameliorates Hepatic Reperfusion Injury after Prolonged Cold Preservation in Isolated Perfused Rat Liver. Artif. Organs
40 (12), 1128–1136. 10.1111/aor.12710
[PubMed] [CrossRef] [Google Scholar]
Song G., Li M., Sang H., Zhang L., Li X., Yao S., et al. (2013). Hydrogen-rich Water Decreases Serum LDL-Cholesterol Levels and Improves HDL Function in Patients with Potential Metabolic Syndrome. J. Lipid Res.
54 (7), 1884–1893. 10.1194/jlr.M036640
[PMC free article] [PubMed] [CrossRef] [Google Scholar]
Song G., Tian H., Liu J., Zhang H., Sun X., Qin S. (2011). H2 Inhibits TNF-α-Induced Lectin-like Oxidized LDL Receptor-1 Expression by Inhibiting Nuclear Factor κB Activation in Endothelial Cells. Biotechnol. Lett.
33 (9), 1715–1722. 10.1007/s10529-011-0630-8
[PubMed] [CrossRef] [Google Scholar]
Sun Q., Kawamura T., Masutani K., Peng X., Sun Q., Stolz D. B., et al. (2012). Oral Intake of Hydrogen-Rich Water Inhibits Intimal Hyperplasia in Arterialized Vein Grafts in Rats. Cardiovasc Res.
94 (1), 144–153. 10.1093/cvr/cvs024
[PMC free article] [PubMed] [CrossRef] [Google Scholar]
Ushida T., Kotani T., Tsuda H., Imai K., Nakano T., Hirako S., et al. (2016). Molecular Hydrogen Ameliorates Several Characteristics of Preeclampsia in the Reduced Uterine Perfusion Pressure (RUPP) Rat Model. Free Radic. Biol. Med.
101, 524–533. 10.1016/j.freeradbiomed.2016.10.491
[PubMed] [CrossRef] [Google Scholar]
Wang K., Dai X., He J., Yan X., Yang C., Fan X., et al. (2020a). Endothelial Overexpression of Metallothionein Prevents Diabetes-Induced Impairment in Ischemia Angiogenesis through Preservation of HIF-1α/SDF-1/VEGF Signaling in Endothelial Progenitor Cells. Diabetes
69 (8), 1779–1792. 10.2337/db19-0829
[PMC free article] [PubMed] [CrossRef] [Google Scholar]
Wang Y., Chen H., Li H., Zhang J., Gao Y. (2013). Effect of Angiopoietin-like Protein 4 on Rat Pulmonary Microvascular Endothelial Cells Exposed to LPS. Int. J. Mol. Med.
32 (3), 568–576. 10.3892/ijmm.2013.1420
[PMC free article] [PubMed] [CrossRef] [Google Scholar]
Wang Y., Wang L., Hu T., Wang F., Han Z., Yin Z., et al. (2020b). Hydrogen Improves Cell Viability Partly through Inhibition of Autophagy and Activation of PI3K/Akt/GSK3β Signal Pathway in a Microvascular Endothelial Cell Model of Traumatic Brain Injury. Neurol. Res.
42 (6), 487–496. 10.1080/01616412.2020.1747717
[PubMed] [CrossRef] [Google Scholar]
Wang Y., Yan W., Lu X., Qian C., Zhang J., Li P., et al. (2011). Overexpression of Osteopontin Induces Angiogenesis of Endothelial Progenitor Cells via the avβ3/PI3K/AKT/eNOS/NO Signaling Pathway in Glioma Cells. Eur. J. Cell Biol.
90 (8), 642–648. 10.1016/j.ejcb.2011.03.005
[PubMed] [CrossRef] [Google Scholar]
Xie K., Yu Y., Pei Y., Hou L., Chen S., Xiong L., et al. (2010). Protective Effects of Hydrogen Gas on Murine Polymicrobial Sepsis via Reducing Oxidative Stress and HMGB1 Release. Shock
34 (1), 90–97. 10.1097/SHK.0b013e3181cdc4ae
[PubMed] [CrossRef] [Google Scholar]
Yang J., Ruan F., Zheng Z. (2018). Ripasudil Attenuates Lipopolysaccharide (LPS)-Mediated Apoptosis and Inflammation in Pulmonary Microvascular Endothelial Cells via ROCK2/eNOS Signaling. Med. Sci. Monit.
24, 3212–3219. 10.12659/msm.910184
[PMC free article] [PubMed] [CrossRef] [Google Scholar]
Yang N., Tian H., Zhan E., Zhai L., Jiao P., Yao S., et al. (2019). Reverse-D-4F Improves Endothelial Progenitor Cell Function and Attenuates LPS-Induced Acute Lung Injury. Respir. Res.
20 (1), 131. 10.1186/s12931-019-1099-6
[PMC free article] [PubMed] [CrossRef] [Google Scholar]
Yu M., Wang C., Zeng G., Zeng G., Zhou L., Chen T., et al. (2017). Toll-like R-eceptor 4 I-s E-xpressed and F-unctional in L-ate E-ndothelial P-rogenitor C-ells. Mol. Med. Rep.
16 (4), 5549–5554. 10.3892/mmr.2017.7291
[PubMed] [CrossRef] [Google Scholar]
Yu X., Song M., Chen J., Zhu G., Zhao G., Wang H., et al. (2010). Hepatocyte Growth Factor Protects Endothelial Progenitor Cell from Damage of Low-Density Lipoprotein Cholesterol via the PI3K/Akt Signaling Pathway. Mol. Biol. Rep.
37 (5), 2423–2429. 10.1007/s11033-009-9753-6
[PubMed] [CrossRef] [Google Scholar]
Zhan Q., Ma X., He Z. (2020). PEAR1 Suppresses the Proliferation of Pulmonary Microvascular Endothelial Cells via PI3K/AKT Pathway in ALI Model. Microvasc. Res.
128, 103941. 10.1016/j.mvr.2019.103941
[PubMed] [CrossRef] [Google Scholar]
Zhao G., Weiner A. I., Neupauer K. M., de Mello Costa M. F., Palashikar G., Adams-Tzivelekidis S., et al. (2020). Regeneration of the Pulmonary Vascular Endothelium after Viral Pneumonia Requires COUP-TF2. Sci. Adv.
6 (48). 10.1126/sciadv.abc4493
[PMC free article] [PubMed] [CrossRef] [Google Scholar]
Zheng X., Zhang W., Hu X. (2018). Different Concentrations of Lipopolysaccharide Regulate Barrier Function through the PI3K/Akt Signalling Pathway in Human Pulmonary Microvascular Endothelial Cells. Sci. Rep.
8 (1), 9963. 10.1038/s41598-018-28089-3
[PMC free article] [PubMed] [CrossRef] [Google Scholar]
Zhou N., Wang L., Fu P., Cui Z., Ge Y., Jiang F., et al. (2021). Conditioned Medium-Preconditioned EPCs Enhanced the Ability in Oligovascular Repair in Cerebral Ischemia Neonatal Rats. Stem Cell Res. Ther.
12 (1), 118. 10.1186/s13287-021-02157-4
[PMC free article] [PubMed] [CrossRef] [Google Scholar]
The Original Article:
original title: Hydrogen Repairs LPS-Induced Endothelial Progenitor Cells Injury via PI3K/AKT/eNOS Pathway
DOI: 10.3389/fphar.2022.894812-
Abstract:
Endotoxins and other harmful substances may cause an increase in permeability in endothelial cells (ECs) monolayers, as well as ECs shrinkage and death to induce lung damage. Lipopolysaccharide (LPS) can impair endothelial progenitor cells (EPCs) functions, including proliferation, migration, and tube formation. EPCs can migrate to the damaged area, differentiate into ECs, and participate in vascular repair, which improves pulmonary capillary endothelial dysfunction and maintains the integrity of the endothelial barrier. Hydrogen (H2) contributes to the repairment of lung injury and the damage of ECs. We therefore speculate that H2 protects the EPCs against LPS-induced damage, and it’s mechanism will be explored. The bone marrow-derived EPCs from ICR Mice were treated with LPS to establish a damaged model. Then EPCs were incubated with H2, and treated with PI3K inhibitor LY294002 and endothelial nitric oxide synthase (eNOS) inhibitor L-NAME. MTT assay, transwell assay and tube formation assay were used to detect the proliferation, migration and angiogenesis of EPCs. The expression levels of target proteins were detected by Western blot. Results found that H2 repaired EPCs proliferation, migration and tube formation functions damaged by LPS. LY294002 and L-NAME significantly inhibited the repaired effect of H2 on LPS-induced dysfunctions of EPCs. H2 also restored levels of phosphor-AKT (p-AKT), eNOS and phosphor-eNOS (p-eNOS) suppressed by LPS. LY294002 significantly inhibited the increase of p-AKT and eNOS and p-eNOS expression exposed by H2. L-NAME significantly inhibited the increase of eNOS and p-eNOS expression induced by H2. H2 repairs the dysfunctions of EPCs induced by LPS, which is mediated by PI3K/AKT/eNOS signaling pathway.
